Chronic kidney disease in India: from a resident physician's perspective.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N Udayakumar.
Explore the source record for details and available documents.
Cerebrovascular manifestations are uncommon presentations of scorpion sting in the Indian subcontinent. A prospective study was carried out on 50 patients with scorpion sting referred to the Government General Hospital during the period from April 2004 to March 2005. In all the patients, detailed history, physical examination with a specific neurological examination and routine biochemical testing and fundus examination were done. Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI) were done in cases with neurological deficit. All these patients also underwent a complete hematological, rheumatologic and cardiovascular work-up for stroke. Cerebrovascular involvement was noted in four patients (8%). Hemorrhagic stroke was noted in two patients (4%) and thrombotic stroke was noted in two patients (4%). The mean time of presentation of neurological symptoms was 2 days. Stroke has been a common presentation in our series (8%). Contrary to world literature, there have been no reports of cranial nerve palsies or neuromuscular involvement in our series.
INTRODUCTION: This project aimed to study the incidence and profile of bone involvement in thyrotoxicosis patients by dual energy X-ray absorptiometry (DEXA) scan and the effect of treatment on the bone mineral density (BMD). METHODS: A total of 50 young patients with a mean age of 29.4 years, diagnosed to have thyrotoxicosis clinically and proven by thyroid function tests, were included in this prospective three-year study conducted at the Madras Medical College and Government General Hospital in Chennai, India. Patients were enrolled if they had bone pain or had elevation of serum alkaline phosphatase. All these patients had a baseline BMD measurement by DEXA scans in the region of the lumbar vertebrae before treatment and the T-score was computed. All other secondary causes of low BMD, like primary hyperparathyroidism, long-term steroid intake, vitamin D deficiency, was ruled out. After definitive management of hyperthyroidism by anti-thyroid drugs and surgery, all the patients with bone involvement had a repeat DEXA scan after one year and the T-score was computed. RESULTS: Out of 50 patients, 46 had bone involvement (92 percent). Based on the World Health Organisation classification, 16 (32 percent) had osteopenia and 30 patients (60 percent) had osteoporosis. After control of thyrotoxicosis, the mean bone mass increased from 0.729 g/sq cm to 0.773 g/sq cm, a statistically significant increase of 0.044 g/sq cm (p-value is less than 0.001) after one year, compared to age- and sex-matched controls. The mean percentage of the bone mass compared to the peak BMD increased from 70.2 percent to 74.2 percent after treatment, an increase of four percent (p-value is less than 0.001). The mean percentage of the bone mass compared to the age-matched BMD increased from 71.2 percent to 75.2 percent after treatment, an increase of four percent (p-value is less than 0.001), all of which were statistically significant. CONCLUSION: Metabolic bone disease should be looked for in all thyrotoxic patients, especially patients complaining of bone pain and those with elevated bone enzymes. DEXA scans offer a convenient, reliable and noninvasive modality for diagnosis and monitoring therapy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.